196 results on '"Knight, Charles J."'
Search Results
2. Complete Versus Culprit-Only Lesion Intervention in Patients With Acute Coronary Syndromes
3. Angiography Alone Versus Angiography Plus Optical Coherence Tomography to Guide Percutaneous Coronary Intervention: Outcomes From the Pan-London PCI Cohort
4. Routine use of fluoroscopic guidance and up-front femoral angiography results in reduced femoral complications in patients undergoing coronary angiographic procedures: an observational study using an Interrupted Time-Series analysis
5. Outcomes after chronic total occlusion percutaneous coronary interventions: an observational study of 5496 patients from the Pan-London CTO Cohort
6. Manual Thrombus Aspiration Is Not Associated With Reduced Mortality in Patients Treated With Primary Percutaneous Coronary Intervention: An Observational Study of 10,929 Patients With ST-Segment Elevation Myocardial Infarction From the London Heart Attack Group
7. An Observational Study Assessing the Predictors of Procedural Failure From the Radial Approach: Is Right Radial Access Always the Best?
8. Contemporary Analysis of Incidence and Outcomes of Stent Thrombosis Presenting as ST Elevation Myocardial Infarction in a Primary Percutaneous Coronary Intervention Cohort
9. Successful Recanalization of Chronic Total Occlusions Is Associated With Improved Long-Term Survival
10. Validation of the CREST score for predicting circulatory-aetiology death in out-of-hospital cardiac arrest without STEMI
11. Long-term Survival in Patients Undergoing Percutaneous Interventions With or Without Intracoronary Pressure Wire Guidance or Intracoronary Ultrasonographic Imaging: A Large Cohort Study
12. Hemoglobin concentration is an independent determinant of heart failure in acute coronary syndromes: cohort analysis of 2310 patients
13. An observational study assessing the impact of a cardiac arrest centre on patient outcomes after out-of-hospital cardiac arrest (OHCA)
14. Clinical outcomes after myocardial revascularization according to operator training status: cohort study of 22 697 patients undergoing percutaneous coronary intervention or coronary artery bypass graft surgery
15. Deployment of drug-eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: A 5-year observational cohort study
16. Safety and feasibility of hospital discharge 2 days following primary percutaneous intervention for ST-segment elevation myocardial infarction
17. Mild chronic kidney disease is an independent predictor of long-term mortality after emergency angiography and primary percutaneous intervention in patients with ST-elevation myocardial infarction
18. Almanac 2011: acute coronary syndromes. The national society journals present selected research that has driven recent advances in clinical cardiology
19. High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction
20. Filters, extractors and other devices in acute myocardial infarction
21. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy
22. Antiplatelet treatment in stable coronary artery disease
23. National Institute for Clinical Excellence guidance: too NICE to glycoprotein IIb/IIIa inhibitors?
24. Five years of percutaneous transluminal septal myocardial ablation
25. Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram
26. Routine use of fluoroscopic guidance and up-front femoral angiography results in reduced femoral complications in patients undergoing coronary angiographic procedures: an observational study using an Interrupted Time-Series analysis
27. Randomised trial of the comparison of drug-eluting stents in patients with diabetes: OCT DES trial
28. Risk scoring to guide antiplatelet therapy post-percutaneous coronary intervention for acute coronary syndrome results in improved clinical outcomes
29. Contemporary trends in cardiogenic shock: Incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group
30. Outcome of 1051 Octogenarian Patients With ST‐Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Observational Cohort From the London Heart Attack Group
31. Controversies Surrounding Renal Denervation: Lessons Learned From Real-World Experience in Two United Kingdom Centers
32. Drug-Eluting Stents Appear Superior to Bare Metal Stents for Vein-Graft PCI in Vessels up to a Stent Diameter of 4 mm
33. The impact of socio-economic status on all-cause mortality after percutaneous coronary intervention: an observational cohort study of 13,770 patients
34. Atypical risk factor profile and excellent long-term outcomes of young patients treated with primary percutaneous coronary intervention for ST-elevation myocardial infarction
35. Risk scoring to guide antiplatelet therapy post-percutaneous coronary intervention for acute coronary syndrome results in improved clinical outcomes.
36. Contemporary trends in cardiogenic shock: Incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group
37. Out-of-hours primary percutaneous coronary intervention for ST-elevation myocardial infarction is not associated with excess mortality: a study of 3347 patients treated in an integrated cardiac network
38. Influence of female sex on long-term mortality after acute coronary syndromes treated by percutaneous coronary intervention
39. Deployment of drug‐eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: A 5‐year observational cohort study
40. Mild chronic kidney disease is an independent predictor of long-term mortality after emergency angiography and primary percutaneous intervention in patients with ST-elevation myocardial infarction
41. Underuse of Thrombolytic Therapy in Acute Myocardial Infarction and Left Bundle Branch Block
42. Reply
43. Did contrast nephropathy in rappid really occur? reply
44. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study
45. A rapid protocol for the prevention of contrast-induced renal dysfunction (RAPPID study)
46. Current management of hypertrophic cardiomyopathy
47. Atypical risk factor profile and excellent long-term outcomes of young patients treated with primary percutaneous coronary intervention for ST-elevation myocardial infarction
48. Haematological abnormalities in rheumatic mitral valve disease
49. Comparison of 201 Tl, 99m Tc-Tetrofosmin, and Dobutamine Magnetic Resonance Imaging for Identifying Hibernating Myocardium
50. Amlodipine Versus Diltiazem as Additional Antianginal Treatment to Atenololfn1fn1This study was sponsored by a grant from Pfizer Ltd, Sandwich, Kent, United Kingdom.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.